Abstract
The actions of the local perivascular application of verapamil to rat mesenteric, pial and cremaster muscle arterioles and muscular venules (15 to 35 micrometers i.d.), was examined in situ, at the microcirculatory level, by use of a high-resolution closed circuit television microscope recording system. Local application of verapamil (1 to 100 micrograms) to cremaster muscle arterioles and venules of the rat induces dose-dependent vasodilatation and increased perfusion of capillaries. However, neither arteriolar nor muscular venular lumen sizes and capillary blood flow of the rat mesenteric or pial vasculatures were altered by even high doses of verapamil. Although these direct in situ microvascular findings do indicate that verapamil can induced dilatation of microscopic resistance and capacitance vessels in skeletal muscle, our data do not support the concept that verapamil induces non-specific peripheral vasodilatation.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Altura B. M., Altura B. T. Peripheral vascular actions of glucocorticoids and their relationship to protection in circulatory shock. J Pharmacol Exp Ther. 1974 Aug;190(2):300–315. [PubMed] [Google Scholar]
- Altura B. M., Gebrewold A., Lassoff S. Biphasic responsiveness of rat pial arterioles to dopamine: direct observations on the microcirculation. Br J Pharmacol. 1980 Aug;69(4):543–544. doi: 10.1111/j.1476-5381.1980.tb07900.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Altura B. M. Pharmacology of venular smooth muscle: new insights. Microvasc Res. 1978 Jul;16(1):91–117. doi: 10.1016/0026-2862(78)90047-x. [DOI] [PubMed] [Google Scholar]
- Baez S. An open cremaster muscle preparation for the study of blood vessels by in vivo microscopy. Microvasc Res. 1973 May;5(3):384–394. doi: 10.1016/0026-2862(73)90054-x. [DOI] [PubMed] [Google Scholar]
- Church J., Zsotér T. T. Calcium antagonistic drugs. Mechanism of action. Can J Physiol Pharmacol. 1980 Mar;58(3):254–264. doi: 10.1139/y80-044. [DOI] [PubMed] [Google Scholar]
- Fleckenstein A. Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Annu Rev Pharmacol Toxicol. 1977;17:149–166. doi: 10.1146/annurev.pa.17.040177.001053. [DOI] [PubMed] [Google Scholar]
- Heupler F. A., Jr, Proudfit W. L. Nifedipine therapy for refractory coronary arterial spasm. Am J Cardiol. 1979 Oct 22;44(5):798–803. doi: 10.1016/0002-9149(79)90200-5. [DOI] [PubMed] [Google Scholar]
- Livesley B., Catley P. F., Campbell R. C., Oram S. Double-blind evaluation of verapamil, propranolol, and isosorbide dinitrate against a placebo in the treatment of angina pectoris. Br Med J. 1973 Feb 17;1(5850):375–378. doi: 10.1136/bmj.1.5850.375. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sandler G., Clayton G. A., Thornicroft S. G. Clinical evaluation of verapamil in angina pectoris. Br Med J. 1968 Jul 27;3(5612):224–227. doi: 10.1136/bmj.3.5612.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schamroth L., Krikler D. M., Garrett C. Immediate effects of intravenous verapamil in cardiac arrhythmias. Br Med J. 1972 Mar 11;1(5801):660–662. doi: 10.1136/bmj.1.5801.660. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yamaguchi I., Ikezawa K., Takada T., Kiyomoto A. Studies on a new 1,5-benzothiazepine derivative (CRD-401) VI. Effects on renal blood flow and renal function. Jpn J Pharmacol. 1974 Aug;24(4):511–522. doi: 10.1254/jjp.24.511. [DOI] [PubMed] [Google Scholar]
- Zsotér T. T. Calcium antagonists. Am Heart J. 1980 Jun;99(6):805–810. doi: 10.1016/0002-8703(80)90633-x. [DOI] [PubMed] [Google Scholar]